-
Vertex Pharmaceuticals' (VRTX) "Overweight" Rating Reaffirmed at Cantor Fitzgerald
Source: Buzz FX / 11 Feb 2025 10:56:10 America/New_York
Vertex Pharmaceuticals' (VRTX) "Overweight" Rating Reaffirmed at Cantor Fitzgerald Written by MarketBeat February 11, 2025 Share Link copied to clipboard. Vertex Pharmaceuticals ( NASDAQ:VRTX - Get Free Report ) 's stock had its "overweight
Read more...